Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease.
about
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future PossibilitiesGadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.StatSensor-i point-of-care creatinine analyzer may identify patients at high-risk of contrast-induced nephropathy.Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.Role of imaging in testicular cancer: current and future practice.Gadolinium-based contrast agents: A comprehensive risk assessment.European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.Pathophysiological Mechanisms in Sclerosing Skin Diseases.Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.Pilot study of non-contrast-enhanced MRI vs. ultrasound in renal transplant recipients with acquired cystic kidney disease: a prospective intra-individual comparison.[Contrast agents in radiology: current agents approved, recommendations, and safety aspects].Arterial spin labeling: a technical overview.Brain relaxometry after macrocyclic Gd-based contrast agent.Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.Probing the brain with molecular fMRI.NSF: still relevant.
P2860
Q30360334-A691C720-F775-4EDC-9F65-B90299BCC133Q31045014-AEA19231-5904-43D8-9C04-D14D3782329CQ33744054-863135B6-6AA4-4157-A9E4-9E987C90A653Q36059081-30891DE3-FFE1-43CA-8969-5879F6BD4FF1Q36431597-75E9A3A9-5131-4E1D-A12D-B3E4EA35912CQ38032230-6C096260-D8D0-4D29-B399-DFD08C65BD97Q38213840-1FB32954-C712-4EB5-899C-008C407E44FEQ38254508-8C4A0818-374F-498C-8625-B54DC1A5A5ECQ38575307-3BC50F38-465D-4436-9A50-C2EC88408F03Q39022872-32FB6341-9B8A-4AD4-8F04-FEAB8CBA5028Q40102390-C1956A6E-AA63-43A2-8C42-FD8670416D97Q41462744-C6766A1A-6044-47D8-AA14-A6DC250852B2Q42318111-CBDD5418-1DA8-4E05-BB8B-4CC13C5BB21AQ42365793-76D935B5-164A-414B-8DEA-707B76603552Q46269179-B6100838-7E92-44EE-861A-304CCD45BB17Q46560085-3D125BFA-236C-4FA0-8DF0-98CEBE554D82Q47725888-819C1B47-2E87-4C08-BDCB-553E442A404FQ48180998-08A0DA72-EAD6-401A-9E79-518F89BDA743Q50417519-D11E273D-F7BB-467A-95C6-E8318E0C2631Q52591528-8AA0985F-C124-4D7D-8346-3E155D37C44FQ54268123-3E540DC4-5855-4F27-9ECC-28D50BEBDBDE
P2860
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@ast
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@en
type
label
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@ast
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@en
prefLabel
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@ast
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@en
P2093
P2860
P356
P1476
Gadolinium-induced nephrogenic ...... fall of an iatrogenic disease.
@en
P2093
A Oliver Sartor
Alanna Murday
Charles L Bennett
Henrik S Thomsen
Sudha Xirasagar
Zaina P Qureshi
P2860
P356
10.1093/CKJ/SFR172
P50
P577
2012-02-01T00:00:00Z